Find your next paid study

Women and Infants Hospital of Rhode IslandNCT06969326

~$50 – $1,500

Actual pay is set by the research site.

Phase 1

Phase Ib/II Study of ZEN003694 and Entinostat in Advanced and Refractory Solid Tumors

This phase I/II trial tests the safety, side effects, and best dose of entinostat and ZEN003694 in treating patients with solid tumors that have spread to othe…

Advanced Malignant Solid NeoplasmLocally Advanced Pancreatic CarcinomaMetastatic Pancreatic Carcinoma+6 more

National Cancer Institute (NCI)NCT05053971

~$150 – $2,700

Actual pay is set by the research site.

Circadian Rhythm Disorders

Effects of Blocking Blue Light at Night on Patient Outcomes After Elective CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH

Purpose The purpose of this study is to determine whether filtering out blue light at nighttime reduces post-surgical inflammation and/or moderates cognitive d…

West Virginia UniversityNCT04578249

Actual pay is set by the research site.

Phase 3

Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery (MD FluNCS)

The investigation will establish biological plausibility and infrastructure required for a multisite clinical trial evaluating the re-purposing of fluvoxamine …

DeliriumSurgery-Complications

Washington University School of MedicineNCT06969287

~$50 – $1,500

Actual pay is set by the research site.

AutismChallenging BehaviorADHD+1 more

RCT of a Measurement Feedback App to Improve Data Quality, Supervision & Outcomes in Behavioral Health

The goal of this clinical trial is to test whether a smartphone-based data collection and feedback application ("Footsteps") improves the quality of behavioral…

University of PennsylvaniaNCT07042347

Actual pay is set by the research site.

Phase 2

Phase II Clinical Trial Combining the Hedgehog Inhibitor Vismodegib With the PD-L1 Inhibitor Atezolizumab in Patients With Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

This trial will treat patients with platinum resistant ovarian, fallopian tube or primary peritoneal cancer as defined by a progression free interval within si…

Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Primary Peritoneal CarcinomaPARP Inhibitor+1 more

Ronald BuckanovichNCT05538091

~$75 – $3,000

Actual pay is set by the research site.

Phase 1

RADIANT Study: Pre-op Radiation With Abemaciclib Andletrozole in Early Stage Breast Cancer

This phase 1b study investigates the safety and feasibility of combining pre-operative radiation therapy with Cyclin-Dependent Kinase 4 (CDK4/6) inhibitors in …

Breast Cancer

Mridula George, MDNCT06139107

~$150 – $4,500

Actual pay is set by the research site.

Early Weight Bearing in Unicondylar Tibial Plateau Fractures: How Does it Affect Gait Pattern, Mobility and Overall Outcome: A Randomized Controlled Trial

The investigators aim of the study is to assess the effects of early mobilization after surgically treated unicondylar tibia plateau fractures (6 weeks without…

Early Mobilization

University of UtahNCT06389240

Actual pay is set by the research site.

Healthy Family Project: Ending Tobacco Use and Smoke Exposure in Asian American Communities

This study evaluates whether the Smokefree Family Living (SFL) intervention improves quit rates (smoking cessation) and exposure to tobacco contamination that …

University of California, San FranciscoNCT07049757

~$10 – $675

Actual pay is set by the research site.

ObesityInsulin SensitivityMuscle Weakness+2 more

Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling

The goal of this intervention study is to learn about how weight loss impacts molecular signaling of intermuscular adipose tissue (IMAT) in individuals with ob…

University of Colorado, DenverNCT06129110

Actual pay is set by the research site.

Phase 1

HM2023-05: GTB-3650 (Anti-CD16/IL-15/Anti-CD33) Tri-Specific Killer Engager (TriKE®) for the Treatment of High Risk Myelodysplastic Syndromes (MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML)

This is a Phase I dose finding study of GTB-3650 (anti-CD16/IL-15/anti-CD33) Tri-Specific Killer Engager (TriKE®) for the treatment of select CD33-expressing r…

Myeloid MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes

Masonic Cancer Center, University of MinnesotaNCT06594445

~$150 – $3,000

Actual pay is set by the research site.

Chronic PainMental Health DisordersBehavioral Health Challenges+1 more

Evaluating the Acceptability, Feasibility and Usability of Various Digital Biopsychosocial Conversational Data Collection Software in a Patient Population With Chronic Pain

This research study is being conducted to evaluate digital software tools that collect health information through conversations. The study will test how accept…